Compounds, compositions and methods are provided for the inhibition of ENPP1. Aspects of the subject methods include contacting a sample with a ENPP1 inhibitor to inhibit cGAMP hydrolysis activity of ENPP1. In some cases, the ENPP1 inhibitor is cell impermeable. Also provided are compositions and methods for treating cancer. Aspects of the methods include administering to a subject a therapeutically effective amount of a ENPP1 inhibitor to treat the subject for cancer. In certain cases, the cancer is a solid tumor cancer. Also provided are methods of administering radiation therapy to a subject either before or after administering an ENPP1 inhibitor. The radiation therapy can be administered at a dosage and/or frequency effective to reduce radiation damage to the subject. In certain cases, the method is performed in combination with a chemotherapeutic agent, or a checkpoint inhibitor, or both.

Compounds, compositions and methods are provided for the inhibition of ENPP1. Aspects of the subject methods include contacting a sample with a ENPP1 inhibitor to inhibit cGAMP hydrolysis activity of ENPP1. In some cases, the ENPP1 inhibitor is cell impermeable. Also provided are compositions and methods for treating cancer. Aspects of the methods include administering to a subject a therapeutically effective amount of a ENPP1 inhibitor to treat the subject for cancer. In certain cases, the cancer is a solid tumor cancer. Also provided are methods of administering radiation therapy to a subject either before or after administering an ENPP1 inhibitor. The radiation therapy can be administered at a dosage and/or frequency effective to reduce radiation damage to the subject. In certain cases, the method is performed in combination with a chemotherapeutic agent, or a checkpoint inhibitor, or both.

The invention relates to chemical compounds and complexes that can be used in therapeutic and diagnostic applications.

Provided herein are metal organic frameworks comprising metal nodes and N-donor organic ligands which have high selectivity and stability in the present of gases and vapors including H.sub.2S, H.sub.2O, and CO.sub.2. Methods include capturing one or more of H.sub.2S, H.sub.2O, and CO.sub.2 from fluid compositions, such as natural gas.

Provided herein are metal organic frameworks comprising metal nodes and N-donor organic ligands which have high selectivity and stability in the present of gases and vapors including H.sub.2S, H.sub.2O, and CO.sub.2. Methods include capturing one or more of H.sub.2S, H.sub.2O, and CO.sub.2 from fluid compositions, such as natural gas.

The present application relates to preparation methods and uses of vanadium complexes providing a consistent and stable preparation. More specifically, the present application relates to preparation of vanadium citrate salts, phosphate salts, or combinations thereof, characterization of the properties of such salts, and methods using the same.

Described herein are metal compounds and methods of fabricating semiconductor devices using the same. The metal compounds include a material of Chemical Formula 1. ##STR00001##

Described herein are compositions and methods relating to molecular cerium-oxide nanoclusters. Described herein are methods of producing cerium-oxide nanoclusters. Described herein are cerium-oxide nanoclusters. Further described herein are cerium-oxide nanoclusters produced by methods as described herein. Methods as described herein can comprise providing a first cerium source, an organic acid, and a solvent; and mixing the cerium source and the organic acid in the presence of a solvent to create a reaction mixture at a temperature and a pressure for a period of time to create a composition of molecular cerium-oxide nanoclusters containing a plurality of molecular cerium-oxide nanoclusters.

Disclosed are a membrane-electrode assembly (MEA) and a method of manufacturing the same. The MEA include an electrolyte membrane and a pair of electrodes, the electrodes being disposed on both surfaces of the electrolyte membrane, respectively. At least one of the electrolyte membranes and electrodes includes an ion-conducting polymer having a proton-conducting functional group, and a compound represented by Chemical Formula 1 is bonded to each of all or some of the proton-conducting functional groups:

MAx  [Chemical Formula 1]

wherein M is an element belonging to the lanthanum group, A is a hydrophilic functional group, and X is a numerical value for balance of charges between A and M. Since the MEA includes an ion-conducting polymer having good chemical durability and proton conductivity, the MEA is durable and has high proton conductivity.

The present disclosure relates to improved processes for the preparation of metal hydrides. The present disclosure also relates to metal hydrides, e.g., metal hydrides prepared by the processes described herein, that exhibit enhanced hydrogen storage capacity when used as hydrogen storage systems.